Loading…

Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility

New pharmaceutical cocrystals of itraconazole (ITR) with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA) were obtained. Cocrystals were found to exhibit higher solubility, Cmax, RAUC, dissolution rate and supersaturation compared to the parent ITR. Binary phase diagrams, FTIR spectra, ho...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2021-04, Vol.599, p.120441-120441, Article 120441
Main Authors: Vasilev, Nikita A., Surov, Artem O., Voronin, Alexander P., Drozd, Ksenia V., Perlovich, German L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173
cites cdi_FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173
container_end_page 120441
container_issue
container_start_page 120441
container_title International journal of pharmaceutics
container_volume 599
creator Vasilev, Nikita A.
Surov, Artem O.
Voronin, Alexander P.
Drozd, Ksenia V.
Perlovich, German L.
description New pharmaceutical cocrystals of itraconazole (ITR) with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA) were obtained. Cocrystals were found to exhibit higher solubility, Cmax, RAUC, dissolution rate and supersaturation compared to the parent ITR. Binary phase diagrams, FTIR spectra, hot stage microscopy and DSC investigations were performed for the obtained forms, with special attention paid to the [ITR+4OHBZA] (1:2) polymorphic forms. [Display omitted] •New solid forms of extremely insoluble antifungal drug itraconazole(ITR) were found.•For a cocrystal with 4-hydroxybenzamide, two enantiomorphic forms were discovered.•Formation thermodynamics of new ITR cocrystals was studied in details.•Cocrystals are found to exhibit higher solubility, Cmax, RAUC, and dissolution rate.•Cocrystals demonstrate significantly better pharmacokinetics compared to pure ITR. In this work, the cocrystallization approach was applied to itraconazole (ITR), a very slightly soluble triazole antifungal drug, which led to the formation of two new solid forms of ITR with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA). A thermodynamic analysis of the solid-liquid binary phase diagrams for the (ITR + 4AmBA) and (ITR + 4OHBZA) systems provided conclusive evidence of the cocrystal stoichiometry: 1:1 for the cocrystal with 4-aminobenzoic acid, and 1:2 for the cocrystal with 4-hydroxybenzamide. Powder X-Ray diffraction analysis confirmed the formation of two different polymorphic forms of the [ITR + 4OHBZA] (1:2) cocrystal obtained either through solution or melt crystallization. Cocrystal formation and polymorphic transition processes were investigated in detail by the DSC and HSM methods. The thermodynamic functions of cocrystal formation were estimated from the solubility of the cocrystals and the corresponding solubility of the pure compounds at different temperatures. The combination of ITR and 4OHBZA was found to be more favorable than the reaction between ITR and 4AmBA in terms of both Gibbs energy and enthalpy. The pH-solubility behavior of the cocrystals was investigated at different pH values using eutectic concentrations of the components and the cocrystal solubility advantage was estimated. It was found that the cocrystallization of itraconazole with 4OHBZA and 4AmBA can potentially increase the drug solubility at pH1.2 and 37 °C by 225 and 64 times, respectively. The cocrystal dissolution behavior in biorelevant media was analyzed in terms of Cmax, σma
doi_str_mv 10.1016/j.ijpharm.2021.120441
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2498518612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517321002465</els_id><sourcerecordid>2498518612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173</originalsourceid><addsrcrecordid>eNqFkMFuEzEURS0EoqHwCVResmCCnz32TLpBVQW0UtVuYG157OfE0Xic2k6l8PVMlZRtV29z3r26h5DPwJbAQH3bLsN2tzE5LjnjsATO2hbekAX0nWhE26m3ZMFE1zcSOnFGPpSyZYwpDuI9ORNCdXLFuwVZ36cnHKlNNh9KNWOhydNQs7FpMn_TiJf0diphvamF-pwinTsLUhfMOptYvlKfcjQ1pInWDeaY3GEyMdhCzeRoSeN-CGOoh4_knZ_T8dPpnpM_P3_8vr5p7h5-3V5f3TW2FVAbaRk4q1SvfM9li7ITFvoVR9Nx74USXHqu_LwLnFN8EG6QAxg-MNPydl56Tr4cc3c5Pe6xVB1DsTiOZsK0L5q3q15Cr4DPqDyiNqdSMnq9yyGafNDA9LNjvdUnx_rZsT46nv8uThX7IaL7__UidQa-HwGchz4FzLrYgJNFFzLaql0Kr1T8A5hnkS8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2498518612</pqid></control><display><type>article</type><title>Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility</title><source>ScienceDirect Freedom Collection</source><creator>Vasilev, Nikita A. ; Surov, Artem O. ; Voronin, Alexander P. ; Drozd, Ksenia V. ; Perlovich, German L.</creator><creatorcontrib>Vasilev, Nikita A. ; Surov, Artem O. ; Voronin, Alexander P. ; Drozd, Ksenia V. ; Perlovich, German L.</creatorcontrib><description>New pharmaceutical cocrystals of itraconazole (ITR) with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA) were obtained. Cocrystals were found to exhibit higher solubility, Cmax, RAUC, dissolution rate and supersaturation compared to the parent ITR. Binary phase diagrams, FTIR spectra, hot stage microscopy and DSC investigations were performed for the obtained forms, with special attention paid to the [ITR+4OHBZA] (1:2) polymorphic forms. [Display omitted] •New solid forms of extremely insoluble antifungal drug itraconazole(ITR) were found.•For a cocrystal with 4-hydroxybenzamide, two enantiomorphic forms were discovered.•Formation thermodynamics of new ITR cocrystals was studied in details.•Cocrystals are found to exhibit higher solubility, Cmax, RAUC, and dissolution rate.•Cocrystals demonstrate significantly better pharmacokinetics compared to pure ITR. In this work, the cocrystallization approach was applied to itraconazole (ITR), a very slightly soluble triazole antifungal drug, which led to the formation of two new solid forms of ITR with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA). A thermodynamic analysis of the solid-liquid binary phase diagrams for the (ITR + 4AmBA) and (ITR + 4OHBZA) systems provided conclusive evidence of the cocrystal stoichiometry: 1:1 for the cocrystal with 4-aminobenzoic acid, and 1:2 for the cocrystal with 4-hydroxybenzamide. Powder X-Ray diffraction analysis confirmed the formation of two different polymorphic forms of the [ITR + 4OHBZA] (1:2) cocrystal obtained either through solution or melt crystallization. Cocrystal formation and polymorphic transition processes were investigated in detail by the DSC and HSM methods. The thermodynamic functions of cocrystal formation were estimated from the solubility of the cocrystals and the corresponding solubility of the pure compounds at different temperatures. The combination of ITR and 4OHBZA was found to be more favorable than the reaction between ITR and 4AmBA in terms of both Gibbs energy and enthalpy. The pH-solubility behavior of the cocrystals was investigated at different pH values using eutectic concentrations of the components and the cocrystal solubility advantage was estimated. It was found that the cocrystallization of itraconazole with 4OHBZA and 4AmBA can potentially increase the drug solubility at pH1.2 and 37 °C by 225 and 64 times, respectively. The cocrystal dissolution behavior in biorelevant media was analyzed in terms of Cmax, σmax parameters (the maximum ITR concentration and supersaturation), and AUC (the concentration area under the curve during the dissolution – supersaturation – precipitation process). The cocrystals had similar σmax values during the dissolution and sustained supersaturation for up to 6 h, which gave them an advantage in the AUC values (13–37 times higher) over the drug. The differences in the dissolution profiles of the cocrystals were rationalized in terms of their dissolution rate values.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2021.120441</identifier><identifier>PMID: 33675927</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cocrystal ; Dissolution rate ; Itraconazole ; Polymorphism ; Supersaturation ; Thermodynamic analysis</subject><ispartof>International journal of pharmaceutics, 2021-04, Vol.599, p.120441-120441, Article 120441</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173</citedby><cites>FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33675927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vasilev, Nikita A.</creatorcontrib><creatorcontrib>Surov, Artem O.</creatorcontrib><creatorcontrib>Voronin, Alexander P.</creatorcontrib><creatorcontrib>Drozd, Ksenia V.</creatorcontrib><creatorcontrib>Perlovich, German L.</creatorcontrib><title>Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>New pharmaceutical cocrystals of itraconazole (ITR) with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA) were obtained. Cocrystals were found to exhibit higher solubility, Cmax, RAUC, dissolution rate and supersaturation compared to the parent ITR. Binary phase diagrams, FTIR spectra, hot stage microscopy and DSC investigations were performed for the obtained forms, with special attention paid to the [ITR+4OHBZA] (1:2) polymorphic forms. [Display omitted] •New solid forms of extremely insoluble antifungal drug itraconazole(ITR) were found.•For a cocrystal with 4-hydroxybenzamide, two enantiomorphic forms were discovered.•Formation thermodynamics of new ITR cocrystals was studied in details.•Cocrystals are found to exhibit higher solubility, Cmax, RAUC, and dissolution rate.•Cocrystals demonstrate significantly better pharmacokinetics compared to pure ITR. In this work, the cocrystallization approach was applied to itraconazole (ITR), a very slightly soluble triazole antifungal drug, which led to the formation of two new solid forms of ITR with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA). A thermodynamic analysis of the solid-liquid binary phase diagrams for the (ITR + 4AmBA) and (ITR + 4OHBZA) systems provided conclusive evidence of the cocrystal stoichiometry: 1:1 for the cocrystal with 4-aminobenzoic acid, and 1:2 for the cocrystal with 4-hydroxybenzamide. Powder X-Ray diffraction analysis confirmed the formation of two different polymorphic forms of the [ITR + 4OHBZA] (1:2) cocrystal obtained either through solution or melt crystallization. Cocrystal formation and polymorphic transition processes were investigated in detail by the DSC and HSM methods. The thermodynamic functions of cocrystal formation were estimated from the solubility of the cocrystals and the corresponding solubility of the pure compounds at different temperatures. The combination of ITR and 4OHBZA was found to be more favorable than the reaction between ITR and 4AmBA in terms of both Gibbs energy and enthalpy. The pH-solubility behavior of the cocrystals was investigated at different pH values using eutectic concentrations of the components and the cocrystal solubility advantage was estimated. It was found that the cocrystallization of itraconazole with 4OHBZA and 4AmBA can potentially increase the drug solubility at pH1.2 and 37 °C by 225 and 64 times, respectively. The cocrystal dissolution behavior in biorelevant media was analyzed in terms of Cmax, σmax parameters (the maximum ITR concentration and supersaturation), and AUC (the concentration area under the curve during the dissolution – supersaturation – precipitation process). The cocrystals had similar σmax values during the dissolution and sustained supersaturation for up to 6 h, which gave them an advantage in the AUC values (13–37 times higher) over the drug. The differences in the dissolution profiles of the cocrystals were rationalized in terms of their dissolution rate values.</description><subject>Cocrystal</subject><subject>Dissolution rate</subject><subject>Itraconazole</subject><subject>Polymorphism</subject><subject>Supersaturation</subject><subject>Thermodynamic analysis</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkMFuEzEURS0EoqHwCVResmCCnz32TLpBVQW0UtVuYG157OfE0Xic2k6l8PVMlZRtV29z3r26h5DPwJbAQH3bLsN2tzE5LjnjsATO2hbekAX0nWhE26m3ZMFE1zcSOnFGPpSyZYwpDuI9ORNCdXLFuwVZ36cnHKlNNh9KNWOhydNQs7FpMn_TiJf0diphvamF-pwinTsLUhfMOptYvlKfcjQ1pInWDeaY3GEyMdhCzeRoSeN-CGOoh4_knZ_T8dPpnpM_P3_8vr5p7h5-3V5f3TW2FVAbaRk4q1SvfM9li7ITFvoVR9Nx74USXHqu_LwLnFN8EG6QAxg-MNPydl56Tr4cc3c5Pe6xVB1DsTiOZsK0L5q3q15Cr4DPqDyiNqdSMnq9yyGafNDA9LNjvdUnx_rZsT46nv8uThX7IaL7__UidQa-HwGchz4FzLrYgJNFFzLaql0Kr1T8A5hnkS8</recordid><startdate>20210415</startdate><enddate>20210415</enddate><creator>Vasilev, Nikita A.</creator><creator>Surov, Artem O.</creator><creator>Voronin, Alexander P.</creator><creator>Drozd, Ksenia V.</creator><creator>Perlovich, German L.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210415</creationdate><title>Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility</title><author>Vasilev, Nikita A. ; Surov, Artem O. ; Voronin, Alexander P. ; Drozd, Ksenia V. ; Perlovich, German L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cocrystal</topic><topic>Dissolution rate</topic><topic>Itraconazole</topic><topic>Polymorphism</topic><topic>Supersaturation</topic><topic>Thermodynamic analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vasilev, Nikita A.</creatorcontrib><creatorcontrib>Surov, Artem O.</creatorcontrib><creatorcontrib>Voronin, Alexander P.</creatorcontrib><creatorcontrib>Drozd, Ksenia V.</creatorcontrib><creatorcontrib>Perlovich, German L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vasilev, Nikita A.</au><au>Surov, Artem O.</au><au>Voronin, Alexander P.</au><au>Drozd, Ksenia V.</au><au>Perlovich, German L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2021-04-15</date><risdate>2021</risdate><volume>599</volume><spage>120441</spage><epage>120441</epage><pages>120441-120441</pages><artnum>120441</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>New pharmaceutical cocrystals of itraconazole (ITR) with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA) were obtained. Cocrystals were found to exhibit higher solubility, Cmax, RAUC, dissolution rate and supersaturation compared to the parent ITR. Binary phase diagrams, FTIR spectra, hot stage microscopy and DSC investigations were performed for the obtained forms, with special attention paid to the [ITR+4OHBZA] (1:2) polymorphic forms. [Display omitted] •New solid forms of extremely insoluble antifungal drug itraconazole(ITR) were found.•For a cocrystal with 4-hydroxybenzamide, two enantiomorphic forms were discovered.•Formation thermodynamics of new ITR cocrystals was studied in details.•Cocrystals are found to exhibit higher solubility, Cmax, RAUC, and dissolution rate.•Cocrystals demonstrate significantly better pharmacokinetics compared to pure ITR. In this work, the cocrystallization approach was applied to itraconazole (ITR), a very slightly soluble triazole antifungal drug, which led to the formation of two new solid forms of ITR with 4-aminobenzoic acid (4AmBA) and 4-hydroxybenzamide (4OHBZA). A thermodynamic analysis of the solid-liquid binary phase diagrams for the (ITR + 4AmBA) and (ITR + 4OHBZA) systems provided conclusive evidence of the cocrystal stoichiometry: 1:1 for the cocrystal with 4-aminobenzoic acid, and 1:2 for the cocrystal with 4-hydroxybenzamide. Powder X-Ray diffraction analysis confirmed the formation of two different polymorphic forms of the [ITR + 4OHBZA] (1:2) cocrystal obtained either through solution or melt crystallization. Cocrystal formation and polymorphic transition processes were investigated in detail by the DSC and HSM methods. The thermodynamic functions of cocrystal formation were estimated from the solubility of the cocrystals and the corresponding solubility of the pure compounds at different temperatures. The combination of ITR and 4OHBZA was found to be more favorable than the reaction between ITR and 4AmBA in terms of both Gibbs energy and enthalpy. The pH-solubility behavior of the cocrystals was investigated at different pH values using eutectic concentrations of the components and the cocrystal solubility advantage was estimated. It was found that the cocrystallization of itraconazole with 4OHBZA and 4AmBA can potentially increase the drug solubility at pH1.2 and 37 °C by 225 and 64 times, respectively. The cocrystal dissolution behavior in biorelevant media was analyzed in terms of Cmax, σmax parameters (the maximum ITR concentration and supersaturation), and AUC (the concentration area under the curve during the dissolution – supersaturation – precipitation process). The cocrystals had similar σmax values during the dissolution and sustained supersaturation for up to 6 h, which gave them an advantage in the AUC values (13–37 times higher) over the drug. The differences in the dissolution profiles of the cocrystals were rationalized in terms of their dissolution rate values.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33675927</pmid><doi>10.1016/j.ijpharm.2021.120441</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2021-04, Vol.599, p.120441-120441, Article 120441
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2498518612
source ScienceDirect Freedom Collection
subjects Cocrystal
Dissolution rate
Itraconazole
Polymorphism
Supersaturation
Thermodynamic analysis
title Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A45%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20cocrystals%20of%20itraconazole:%20Insights%20from%20phase%20diagrams,%20formation%20thermodynamics%20and%20solubility&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Vasilev,%20Nikita%20A.&rft.date=2021-04-15&rft.volume=599&rft.spage=120441&rft.epage=120441&rft.pages=120441-120441&rft.artnum=120441&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2021.120441&rft_dat=%3Cproquest_cross%3E2498518612%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-5c01dc6686f8254e573c1892ea72ff36325f26f3781dd62b3db5b1a2b0a424173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2498518612&rft_id=info:pmid/33675927&rfr_iscdi=true